VIRA KOMENDYAK: Open Payments
NPI 1811286222 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,323 in 26 payments from 9 companies in 2025. Trend: 2023 $180 · 2024 $87 · 2025 $1,323
Food & beverage: $1,323
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 11 | $597 |
| ABBVIE INC. | 5 | $179 |
| Alkermes, Inc. | 2 | $149 |
| Axsome Therapeutics, Inc. | 1 | $125 |
| Ardelyx, Inc. | 1 | $121 |
| Lundbeck LLC | 3 | $80 |
| Janssen Pharmaceuticals, Inc | 1 | $30 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $23 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $18 |
Products named: REXULTI, QULIPTA, LYBALVI, Auvelity, IBSRELA, SPRAVATO, UBRELVY, CAPLYTA.
Industry payments across NY — which companies pay providers there.
